A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions.
|Drug||Drug Name||Drug Indication|
|DB00233||Aminosalicylic Acid||For the treatment of tuberculosis|
|DB00244||Mesalazine||Mesalazine is indicated for the induction of remission in patients with active or mild to moderate acute exacerbations of ulcerative colitis and for the maintenance of remission of ulcerative colitis [FDA Label], [L5101]. Prescribing information for mesalazine in the UK also indicates the medication for the maintenance of remission of Crohn's ileo-colitis [L5101].|
|DB01014||Balsalazide||For the treatment of mildly to moderately active ulcerative colitis.|